TrademarkDir
KRIYA RESEARCH AND DEVELOPMENT
LIVE

Serial Number

97215786

Owner

Kriya Therapeutics, Inc.

Attorney

Monica Riva Talley

First Use Date

Jun 26, 2024

Filing Date

Jan 12, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KRIYA RESEARCH AND DEVELOPMENT Trademark

Serial Number: 97215786 • Registration: 8335708

KRIYA RESEARCH AND DEVELOPMENT is a trademark filed by Kriya Therapeutics, Inc. on January 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Kriya Therapeutics, Inc. (24 trademarks)

Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

January 12, 2022

Registration Date

July 7, 2026

First Use Anywhere

June 26, 2024

First Use in Commerce

June 26, 2024

Published for Opposition

March 14, 2023

Goods & Services

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, musculoskeletal, cardiovascular, hepatological, hormonal, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, musculoskeletal, cardiovascular, and hepatological diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 15, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 15, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 21, 2026 SUPC
USE AMENDMENT FILED
May 11, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
May 11, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 19, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 5, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 1, 2025 EX4G
SOU EXTENSION 4 FILED
Apr 30, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 31, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 31, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 29, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 29, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 29, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 23, 2024 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 3, 2024 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2024 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 1, 2024 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 6, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 10, 2023 COAR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 2, 2023 XAEC
ASSIGNED TO LIE
Feb 2, 2023 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 2, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 2, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 2, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 1, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2022 NWOS
NEW APPLICATION ENTERED
Jan 15, 2022 NWAP

Related Trademarks

More from this Owner

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY